- Financial Times•3 days ago
The suspense inside the offices of Eli Lilly this autumn was all but unbearable. After working on a drug to fight Alzheimer's disease for 15 years, employees of the Midwestern drugmaker were about to find ...
- Financial Times•4 days ago
On Chicago's outskirts sits a sprawling corporate campus set on more than 450 acres. It is home to Abbott Laboratories, the healthcare group, and AbbVie, the drugmaker it spun out in 2013. A grid of roads ...
- Financial Times•5 days ago
Actelion, Europe's largest biotech company, is considering a complicated deal to combine with part of Johnson & Johnson, a move that will leave the Swiss company independent from the US drugs giant, people ...
ROG.VX : Summary for ROCHE GS - Yahoo Finance
Roche Holding AG (ROG.VX)
Swiss - Swiss Delayed Price. Currency in CHF
Add to watchlist
|Bid||220.60 x 243000|
|Ask||218.00 x 260500|
|Day's Range||218.30 - 221.10|
|52 Week Range||218.30 - 279.50|
|PE Ratio (TTM)||21.28|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|